Asarfi Hospital Ltd
Incorporated in 2005, Asarfi Hospital Ltd
provides primary health services & treatment
and specialized super speciality health service[1]
- Market Cap ₹ 271 Cr.
- Current Price ₹ 138
- High / Low ₹ 150 / 52.8
- Stock P/E 25.6
- Book Value ₹ 41.2
- Dividend Yield 0.00 %
- ROCE 15.9 %
- ROE 14.0 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 44.9 days to 93.1 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Mar 2025 | |
---|---|---|
81 | 121 | |
65 | 97 | |
Operating Profit | 16 | 24 |
OPM % | 20% | 20% |
2 | 8 | |
Interest | 3 | 4 |
Depreciation | 9 | 13 |
Profit before tax | 6 | 14 |
Tax % | 33% | 26% |
4 | 11 | |
EPS in Rs | 2.11 | 5.38 |
Dividend Payout % | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 49% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 154% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 96% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Mar 2025 | |
---|---|---|
Equity Capital | 20 | 20 |
Reserves | 51 | 61 |
32 | 49 | |
52 | 34 | |
Total Liabilities | 154 | 164 |
94 | 102 | |
CWIP | 0 | 2 |
Investments | 0 | 0 |
60 | 60 | |
Total Assets | 154 | 164 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Mar 2025 | |
---|---|---|
26 | -4 | |
-63 | -7 | |
36 | 13 | |
Net Cash Flow | -1 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2024 | Mar 2025 | |
---|---|---|
Debtor Days | 109 | 120 |
Inventory Days | 32 | 30 |
Days Payable | 447 | 171 |
Cash Conversion Cycle | -305 | -20 |
Working Capital Days | -3 | 93 |
ROCE % | 16% |
Documents
Announcements
-
Closure of Trading Window
27 Jun - Trading window closed from July 1, 2025, till 48 hours post June 30 quarter results announcement.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
6 Jun - Investor call scheduled for June 9, 2025, discussing publicly available information only.
-
Appointment of Company Secretary and Compliance Officer
4 Jun - Appointment of Sudipa Singh as Company Secretary and Compliance Officer effective 03/06/2025.
-
Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Appointment Of Compliance Officer Cum Company Secretary.
4 Jun - Appointment of Sudipa Singh as Company Secretary and Compliance Officer effective 03/06/2025.
-
Integrated Filing (Financial)
24 May - Audited FY25 financial results approved; new auditor appointed; unmodified audit opinion received.
Annual reports
Concalls
-
May 2025Transcript PPT
-
Jan 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
Business Overview Asarfi Hospital Limited (AHL) operates three primary facilities:
Pharmacy Contribution: The hospital’s pharmacy contributed 25% of the revenue
Asarfi Cancer Institute (Ranguni, Dhanbad)[2]
Future Expansion: The facility is approved for construction of up to seven floors, enabling substantial expansion.
Research Institute (Ranchi)[3]